| Antoni Jan Gofron, MD | |
|
788 N Jefferson St, Suite 201, Milwaukee, WI 53202-3718 | |
| (414) 226-4010 | |
| (414) 274-6270 |
| Full Name | Antoni Jan Gofron |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 33 Years |
| Location | 788 N Jefferson St, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871501593 | NPI | - | NPPES |
| 1871501593 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 49567 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Columbia St Mary's Hospital Milwaukee | Milwaukee, WI | Hospital |
| Ascension Se Wisconsin Hospital - St Joseph Campus | Milwaukee, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Columbia St Marys Hospital Milwaukee Inc | 5890604722 | 279 |
| Madison Medical Affiliates Inc | 5991606337 | 84 |
News Archive
A team of local researchers has proposed a molecular mechanism that may be responsible for the development of life-threatening diseases called amyloidoses. The best known of such diseases is Alzheimer's disease (AD), but there are many others that are receiving increased scrutiny, in part because of mounting evidence linking them to atherosclerosis and aging.
Concern about the size and cost of Medicare is understandable. With 10,000 or so baby boomers due to reach age 65 every day for the next 18 years, Medicare enrollment is exploding, and based on our projections, by 2023 - 10 years from now - should reach 66 million, up from 50.3. The need to find better ways to deliver quality health care to seniors at a reasonable cost is obvious. What's interesting is that an effective way to do this already exists: the Medicare Advantage program, which some in Washington are seeking to curtail (Daniel Gorlin and John Kaplan, 7/2).
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense medical countermeasures where there remains an unmet medical need, announced today that it has been awarded a contract valued at up to $6.4 million by the US Department of Health and Human Service's National Institutes of Health (specifically funded by the National Institute of Allergy and Infectious Diseases or NIAID).
People on Medicaid who work rural seasonal jobs in Montana are wondering about the future of their access to health coverage. Montana recently passed a law that, if it gains federal approval and goes into effect as planned in January, would require many Medicaid recipients to prove they work a set number of hours each month.
› Verified 2 days ago
| Entity Name | Columbia St Marys Hospital Milwaukee Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023064482 PECOS PAC ID: 5890604722 Enrollment ID: O20031105000057 |
News Archive
A team of local researchers has proposed a molecular mechanism that may be responsible for the development of life-threatening diseases called amyloidoses. The best known of such diseases is Alzheimer's disease (AD), but there are many others that are receiving increased scrutiny, in part because of mounting evidence linking them to atherosclerosis and aging.
Concern about the size and cost of Medicare is understandable. With 10,000 or so baby boomers due to reach age 65 every day for the next 18 years, Medicare enrollment is exploding, and based on our projections, by 2023 - 10 years from now - should reach 66 million, up from 50.3. The need to find better ways to deliver quality health care to seniors at a reasonable cost is obvious. What's interesting is that an effective way to do this already exists: the Medicare Advantage program, which some in Washington are seeking to curtail (Daniel Gorlin and John Kaplan, 7/2).
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense medical countermeasures where there remains an unmet medical need, announced today that it has been awarded a contract valued at up to $6.4 million by the US Department of Health and Human Service's National Institutes of Health (specifically funded by the National Institute of Allergy and Infectious Diseases or NIAID).
People on Medicaid who work rural seasonal jobs in Montana are wondering about the future of their access to health coverage. Montana recently passed a law that, if it gains federal approval and goes into effect as planned in January, would require many Medicaid recipients to prove they work a set number of hours each month.
› Verified 2 days ago
| Entity Name | Madison Medical Affiliates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588695746 PECOS PAC ID: 5991606337 Enrollment ID: O20040119000018 |
News Archive
A team of local researchers has proposed a molecular mechanism that may be responsible for the development of life-threatening diseases called amyloidoses. The best known of such diseases is Alzheimer's disease (AD), but there are many others that are receiving increased scrutiny, in part because of mounting evidence linking them to atherosclerosis and aging.
Concern about the size and cost of Medicare is understandable. With 10,000 or so baby boomers due to reach age 65 every day for the next 18 years, Medicare enrollment is exploding, and based on our projections, by 2023 - 10 years from now - should reach 66 million, up from 50.3. The need to find better ways to deliver quality health care to seniors at a reasonable cost is obvious. What's interesting is that an effective way to do this already exists: the Medicare Advantage program, which some in Washington are seeking to curtail (Daniel Gorlin and John Kaplan, 7/2).
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense medical countermeasures where there remains an unmet medical need, announced today that it has been awarded a contract valued at up to $6.4 million by the US Department of Health and Human Service's National Institutes of Health (specifically funded by the National Institute of Allergy and Infectious Diseases or NIAID).
People on Medicaid who work rural seasonal jobs in Montana are wondering about the future of their access to health coverage. Montana recently passed a law that, if it gains federal approval and goes into effect as planned in January, would require many Medicaid recipients to prove they work a set number of hours each month.
› Verified 2 days ago
| Entity Name | Wisconsin Health Fund |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497768659 PECOS PAC ID: 3072401298 Enrollment ID: O20040309000864 |
News Archive
A team of local researchers has proposed a molecular mechanism that may be responsible for the development of life-threatening diseases called amyloidoses. The best known of such diseases is Alzheimer's disease (AD), but there are many others that are receiving increased scrutiny, in part because of mounting evidence linking them to atherosclerosis and aging.
Concern about the size and cost of Medicare is understandable. With 10,000 or so baby boomers due to reach age 65 every day for the next 18 years, Medicare enrollment is exploding, and based on our projections, by 2023 - 10 years from now - should reach 66 million, up from 50.3. The need to find better ways to deliver quality health care to seniors at a reasonable cost is obvious. What's interesting is that an effective way to do this already exists: the Medicare Advantage program, which some in Washington are seeking to curtail (Daniel Gorlin and John Kaplan, 7/2).
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense medical countermeasures where there remains an unmet medical need, announced today that it has been awarded a contract valued at up to $6.4 million by the US Department of Health and Human Service's National Institutes of Health (specifically funded by the National Institute of Allergy and Infectious Diseases or NIAID).
People on Medicaid who work rural seasonal jobs in Montana are wondering about the future of their access to health coverage. Montana recently passed a law that, if it gains federal approval and goes into effect as planned in January, would require many Medicaid recipients to prove they work a set number of hours each month.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Antoni Jan Gofron, MD 788 N Jefferson St, Suite 300/attn. Kaaren Butzen, Milwaukee, WI 53202-3718 Ph: (414) 272-8950 | Antoni Jan Gofron, MD 788 N Jefferson St, Suite 201, Milwaukee, WI 53202-3718 Ph: (414) 226-4010 |
News Archive
A team of local researchers has proposed a molecular mechanism that may be responsible for the development of life-threatening diseases called amyloidoses. The best known of such diseases is Alzheimer's disease (AD), but there are many others that are receiving increased scrutiny, in part because of mounting evidence linking them to atherosclerosis and aging.
Concern about the size and cost of Medicare is understandable. With 10,000 or so baby boomers due to reach age 65 every day for the next 18 years, Medicare enrollment is exploding, and based on our projections, by 2023 - 10 years from now - should reach 66 million, up from 50.3. The need to find better ways to deliver quality health care to seniors at a reasonable cost is obvious. What's interesting is that an effective way to do this already exists: the Medicare Advantage program, which some in Washington are seeking to curtail (Daniel Gorlin and John Kaplan, 7/2).
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense medical countermeasures where there remains an unmet medical need, announced today that it has been awarded a contract valued at up to $6.4 million by the US Department of Health and Human Service's National Institutes of Health (specifically funded by the National Institute of Allergy and Infectious Diseases or NIAID).
People on Medicaid who work rural seasonal jobs in Montana are wondering about the future of their access to health coverage. Montana recently passed a law that, if it gains federal approval and goes into effect as planned in January, would require many Medicaid recipients to prove they work a set number of hours each month.
› Verified 2 days ago
Julia Bonner, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 3351 North Downer Avenue, Milwaukee, WI 53211 Phone: 414-229-5684 | |
Dr. Zachary Smith, DO Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-955-6830 Fax: 414-955-6214 | |
Dr. Christopher Patrick Boyd, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-6000 Fax: 414-805-6280 | |
Umair Bajwa, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-0812 Fax: 414-805-0855 | |
Dr. Jeffrey Wilson, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1020 N 12th St, Ste 206, Milwaukee, WI 53233 Phone: 414-219-7136 | |
Rasika Surajyam Chepuri, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-955-7040 Fax: 414-955-6211 | |
Soryal A Soryal, M.D Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1020 N 12th St, 3rd Floor, Milwaukee, WI 53233 Phone: 414-219-7300 |